Antiproliferative effect of gold(I) compound auranofin through inhibition of STAT3 and telomerase activity in MDA-MB 231 human breast cancer cells
Authors:
- Hyo Jung ParkHPHyo Jung Park
- Mi-Kyung OhMOMi-Kyung Oh
- In-Sook KimIKIn-Sook Kim
Open Access
- 31 January 2013
- journal article
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 46 (1) , 59-64
Abstract
Signal transducer and activator of transcription 3 (STAT3) and telomerase are considered attractive targets for anticancer therapy. The in vitro anticancer activity of the gold(I) compound auranofin was investigated using MDA-MB 231 human breast cancer cells, in which STAT3 is constitutively active. In cell culture, auranofin inhibited growth in a dose-dependent manner, and N-acetyl-L-cysteine (NAC), a scavenger of reactive oxygen species (ROS), markedly blocked the effect of auranofin. Incorporation of 5-bromo-2’-deoxyuridine into DNA and anchorage-independent cell growth on soft agar were decreased by auranofin treatment. STAT3 phosphorylation and telomerase activity were also attenuated in cells exposed to auranofin, but NAC pretreatment restored STAT3 phosphorylation and telomerase activity in these cells. These findings indicate that auranofin exerts in vitro antitumor effects in MDA-MB 231 cells and its activity involves inhibition of STAT3 and telomerase. Thus, auranofin shows potential as a novel anticancer drug that targets STAT3 and telomerase. [BMB Reports 2013; 46(1): 59-64]Keywords
This publication has 29 references indexed in Scilit:
- Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancerBreast Cancer Research, 2012
- Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by AuranofinJournal of Biological Chemistry, 2009
- Manumycin inhibits STAT3, telomerase activity, and growth of glioma cells by elevating intracellular reactive oxygen species generationFree Radical Biology and Medicine, 2009
- Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studiesMedicinal Research Reviews, 2009
- Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidationBiochemical and Biophysical Research Communications, 2008
- Auranofin blocks interleukin‐6 signalling by inhibiting phosphorylation of JAK1 and STAT3Immunology, 2007
- The role of p38 MAPK activation in auranofin‐induced apoptosis of human promyelocytic leukaemia HL‐60 cellsBritish Journal of Pharmacology, 2005
- Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitroBritish Journal of Pharmacology, 2004
- Gold compound auranofin inhibits IκB kinase (IKK) by modifying Cys-179 of IKKβ subunitExperimental & Molecular Medicine, 2003
- Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptorsOncogene, 2000